Related references
Note: Only part of the references are listed.Impact of the type of electroanatomic mapping system on the incidence of cerebral embolism after radiofrequency catheter ablation of left atrial tachycardias
Kohki Nakamura et al.
HEART RHYTHM (2020)
Ultrasound guidance for femoral venous access in electrophysiology procedures-systematic review and meta-analysis
Peter Kupo et al.
JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY (2020)
UNINTERRUPTED VS. INTERRUPTED NOVEL ORAL ANTICOAGULANT (NOAC) DOSING STRATEGY BEFORE CATHETER ABLATION OF ATRIAL FIBRILLATION: A METANALYSIS OF RANDOMIZED CONTROLLED TRIALS FOR PERIPROCEDURAL COMPLICATIONS
Indranill Basu Ray et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Peri-procedural novel oral anticoagulants dosing strategy during atrial fibrillation ablation: A meta-analysis
Yin-Jun Mao et al.
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY (2020)
Uninterrupted vs. interrupted periprocedural direct oral anticoagulants for catheter ablation of atrial fibrillation: a prospective randomized single-centre study on post-ablation thrombo-embolic and haemorrhagic events
Kohki Nakamura et al.
EUROPACE (2019)
Safety and efficacy of uninterrupted vs. minimally interrupted periprocedural direct oral anticoagulants for catheter ablation of atrial fibrillation: two sides of the same coin?
Luigi Di Biase et al.
EUROPACE (2019)
Silent cerebral events/lesions after second-generation cryoballoon ablation: How can we reduce the risk of silent strokes?
Shinsuke Miyazaki et al.
HEART RHYTHM (2019)
Impact of periprocedural anticoagulation therapy on the incidence of silent stroke after atrial fibrillation ablation in patients receiving direct oral anticoagulants: uninterrupted vs. interrupted by one dose strategy
Tomoyuki Nagao et al.
EUROPACE (2019)
Uninterrupted edoxaban vs. vitamin K antagonists for ablation of atrial fibrillation: the ELIMINATE-AF trial
Stefan H. Hohnloser et al.
EUROPEAN HEART JOURNAL (2019)
Clinical comparative study regarding interrupted and uninterrupted dabigatran therapy during perioperative periods of cryoballoon ablation for paroxysmal atrial fibrillation
Rena Nakamura et al.
JOURNAL OF CARDIOLOGY (2019)
Same-day discharge in selected patients undergoing atrial fibrillation ablation
Stefano Bartoletti et al.
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY (2019)
To continue or minimally interrupt direct oral anticoagulants around ablation for atrial fibrillation: that is the question
David H. Birnie
EUROPACE (2019)
Postablation cerebral embolisms in balloon-based atrial fibrillation ablation with periprocedural direct oral anticoagulants: A comparison between cryoballoon and HotBalloon ablation
Kohki Nakamura et al.
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY (2019)
2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary
Hugh Calkins et al.
EUROPACE (2018)
Apixaban in patients at risk of stroke undergoing atrial fibrillation ablation
Paulus Kirchhof et al.
EUROPEAN HEART JOURNAL (2018)
The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
Jan Steffel et al.
EUROPEAN HEART JOURNAL (2018)
Renal function and risk of stroke and bleeding in patients undergoing catheter ablation for atrial fibrillation: Comparison between uninterrupted direct oral anticoagulants and warfarin administration
Satoshi Yanagisawa et al.
HEART RHYTHM (2018)
An updated meta-analysis of novel oral anticoagulants versus vitamin K antagonists for uninterrupted anticoagulation in atrial fibrillation catheter ablation
Rhanderson Cardoso et al.
HEART RHYTHM (2018)
A Prospective Randomized Trial of Apixaban Dosing During Atrial Fibrillation Ablation The AEIOU Trial
Matthew R. Reynolds et al.
JACC-CLINICAL ELECTROPHYSIOLOGY (2018)
Incidence of silent cerebral infarctions after catheter ablation of atrial fibrillation utilizing the second-generation cryoballoon
Tomofumi Nakamura et al.
EUROPACE (2017)
Thromboembolic and bleeding risks in patients undergoing atrial fibrillation ablation: oral anticoagulation perspectives
David F. Briceno et al.
EXPERT OPINION ON DRUG SAFETY (2017)
Uninterrupted Dabigatran versus Warfarin for Ablation in Atrial Fibrillation
Hugh Calkins et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Paulus Kirchhof et al.
EUROPEAN HEART JOURNAL (2016)
Impact of periprocedural anticoagulation strategy on the incidence of new-onset silent cerebral events after radiofrequency catheter ablation of atrial fibrillation
Patrick Mueller et al.
JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY (2016)
Oral anticoagulant therapy for stroke prevention in patients with atrial fibrillation undergoing ablation: results from the First European Snapshot Survey on Procedural Routines for Atrial Fibrillation Ablation (ESS-PRAFA)
Tatjana S. Potpara et al.
EUROPACE (2015)
Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation
Riccardo Cappato et al.
EUROPEAN HEART JOURNAL (2015)
Silent Cerebral Events/Lesions Related to Atrial Fibrillation Ablation: A Clinical Review
Thomas Deneke et al.
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY (2015)
Catheter Ablation to Maintain Sinus Rhythm
Hugh Calkins
CIRCULATION (2012)
Updated Worldwide Survey on the Methods, Efficacy, and Safety of Catheter Ablation for Human Atrial Fibrillation
Riccardo Cappato et al.
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2010)
Neuropsychological decline after catheter ablation of atrial fibrillation
Niko Schwarz et al.
HEART RHYTHM (2010)
Random effects meta-analysis of event outcome in the framework of the generalized linear mixed model with applications in sparse data
Theo Stijnen et al.
STATISTICS IN MEDICINE (2010)
Current status and outcomes of catheter ablation for atrial fibrillation
Thomas Crawford et al.
HEART RHYTHM (2009)
Share Paper
